المؤلفون: Martín M; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain.; Universidad Complutense de Madrid, Madrid, Spain., Yoder R; The University of Kansas Cancer Center, Westwood, Kansas., Salgado R; ZAS Hospitals, Antwerp, Belgium., Del Monte-Millán M; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Álvarez EL; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Echavarría I; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Staley JM; The University of Kansas Cancer Center, Westwood, Kansas., O'Dea AP; University of Kansas Medical Center, Westwood, Kansas., Nye LE; University of Kansas Medical Center, Westwood, Kansas., Stecklein SR; University of Kansas Medical Center, Kansas City, Kansas., Bueno C; Hospital Infanta Cristina (Parla), Madrid, Spain., Jerez Y; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Cebollero M; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Bueno O; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., García Saenz JÁ; Hospital Clínico San Carlos, Madrid, Spain., Moreno F; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain., Bohn U; Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, Canary Islands., Gómez H; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Massarrah T; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Khan QJ; University of Kansas Medical Center, Westwood, Kansas., Godwin AK; University of Kansas Medical Center, Kansas City, Kansas., López-Tarruella S; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain.; Universidad Complutense de Madrid, Madrid, Spain., Sharma P; University of Kansas Medical Center, Westwood, Kansas.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2160-2169.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Lymphocytes, Tumor-Infiltrating*/immunology , Neoadjuvant Therapy*/methods , Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/mortality , Triple Negative Breast Neoplasms*/pathology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Female ; Middle Aged ; Adult ; Aged ; Anthracyclines/administration & dosage ; Anthracyclines/therapeutic use ; Prognosis ; Neoplasm Staging ; Treatment Outcome ; Docetaxel/administration & dosage ; Docetaxel/therapeutic use ; Carboplatin/administration & dosage

المؤلفون: Stecklein SR; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Kimler BF; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA., Yoder R; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Schwensen K; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Staley JM; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Khan QJ; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., O'Dea AP; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Nye LE; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Elia M; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Heldstab J; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Home T; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Hyter S; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Isakova K; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Pathak HB; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA., Sharma P; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA. psharma2@kumc.edu.; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA. psharma2@kumc.edu.

المصدر: NPJ breast cancer [NPJ Breast Cancer] 2023 Mar 06; Vol. 9 (1), pp. 10. Date of Electronic Publication: 2023 Mar 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

المؤلفون: Adams S; New York University Perlmutter Cancer Center, NYU Langone Health, New York, New York. sylvia.adams@nyulangone.org., Othus M; SWOG Statistics and Data Management Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington., Patel SP; University of California San Diego Moores Cancer Center, La Jolla, California., Miller KD; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana., Chugh R; University of Michigan, Ann Arbor, Michigan., Schuetze SM; University of Michigan, Ann Arbor, Michigan., Chamberlin MD; Dartmouth-Hitchcock Medical Center/Norris Cotton Cancer Center, Lebanon, New Hampshire., Haley BJ; UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas., Storniolo AMV; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana., Reddy MP; Dayton Physicians LLC-Atrium Hematology Medical Oncology Division (Dayton NCORP), Franklin, Ohio., Anderson SA; Goldschmidt Cancer Center, Capital Region Southwest Campus (Heartland NCORP), Jefferson City, Missouri., Zimmerman CT; Kaiser Permanente Medical Group (Kaiser Perm NCORP), San Diego, California., O'Dea AP; University of Kansas Hospital-Westwood Cancer Center (Kansas MU-NCORP), Westwood, Kansas., Mirshahidi HR; Loma Linda University Cancer Center, Loma Linda, California., Ahnert JR; MD Anderson Cancer Center, Houston, Texas., Brescia FJ; MUSC, Hollings Cancer Center (MUSC MU-NCORP), Charleston, South Carolina., Hahn O; University of Chicago Comprehensive Cancer Center, Chicago, Illinois., Raymond JM; Allegheny General Hospital, Pittsburgh, Pennsylvania., Biggs DD; Centura Health, Frisco, Colorado., Connolly RM; Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland., Sharon E; National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, Maryland., Korde LA; National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, Maryland., Gray RJ; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Mayerson E; SWOG Statistics and Data Management Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington., Plets M; SWOG Statistics and Data Management Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington., Blanke CD; SWOG Group Chair's Office, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Chae YK; Northwestern University, Chicago, Illinois., Kurzrock R; University of California San Diego Moores Cancer Center, La Jolla, California.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jan 15; Vol. 28 (2), pp. 271-278. Date of Electronic Publication: 2021 Oct 29.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Breast Neoplasms*/drug therapy, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Ipilimumab/therapeutic use ; Middle Aged ; Nivolumab/therapeutic use ; Prospective Studies

المؤلفون: Sharma P; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas. psharma2@kumc.edu mmartin@geicam.org., López-Tarruella S; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., García-Saenz JA; Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain., Khan QJ; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Gómez HL; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú., Prat A; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Moreno F; Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain., Jerez-Gilarranz Y; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., Barnadas A; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Picornell AC; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., Monte-Millán MD; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., González-Rivera M; Laboratory of Translational Oncology, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain., Massarrah T; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., Pelaez-Lorenzo B; Department of Oncology, Hospital Clínico, Valladolid, Spain., Palomero MI; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., González Del Val R; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., Cortés J; Department of Oncology, Ramón y Cajal University Hospital, Madrid, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Fuentes-Rivera H; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú., Morales DB; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú., Márquez-Rodas I; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., Perou CM; Departments of Genetics and Pathology & Laboratory Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Lehn C; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Wang YY; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Klemp JR; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Mammen JV; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Wagner JL; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Amin AL; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., O'Dea AP; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Heldstab J; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Jensen RA; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Kimler BF; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Godwin AK; Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kansas., Martín M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain. psharma2@kumc.edu mmartin@geicam.org.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Dec 01; Vol. 24 (23), pp. 5820-5829. Date of Electronic Publication: 2018 Jul 30.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Triple Negative Breast Neoplasms/*drug therapy , Triple Negative Breast Neoplasms/*mortality, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biomarkers, Tumor ; Carboplatin/administration & dosage ; Combined Modality Therapy ; Docetaxel/administration & dosage ; Female ; Genes, BRCA1 ; Genes, BRCA2 ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Grading ; Neoplasm Metastasis ; Neoplasm Staging ; Prognosis ; Treatment Outcome ; Triple Negative Breast Neoplasms/pathology

المؤلفون: Kilgore LJ; Division of Breast Surgery, Department of Surgery, University of Kansas Cancer Center, Kansas City, KS, USA., Korentager SS; Division of Breast Surgery, Department of Surgery, University of Kansas Cancer Center, Kansas City, KS, USA., Hangge AN; Division of Breast Surgery, Department of Surgery, University of Kansas Cancer Center, Kansas City, KS, USA., Amin AL; Division of Breast Surgery, Department of Surgery, University of Kansas Cancer Center, Kansas City, KS, USA., Balanoff CR; Division of Breast Surgery, Department of Surgery, University of Kansas Cancer Center, Kansas City, KS, USA., Larson KE; Division of Breast Surgery, Department of Surgery, University of Kansas Cancer Center, Kansas City, KS, USA., Mitchell MP; Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, KS, USA., Chen JG; Office of Scholarly, Academic and Research Mentoring, University of Kansas Cancer Center, Kansas City, KS, USA., Burgen E; Office of Scholarly, Academic and Research Mentoring, University of Kansas Cancer Center, Kansas City, KS, USA., Khan QJ; Department of Medical Oncology, University of Kansas Cancer Center, Kansas City, KS, USA., O'Dea AP; Department of Medical Oncology, University of Kansas Cancer Center, Kansas City, KS, USA., Nye L; Department of Medical Oncology, University of Kansas Cancer Center, Kansas City, KS, USA., Sharma P; Department of Medical Oncology, University of Kansas Cancer Center, Kansas City, KS, USA., Wagner JL; Division of Breast Surgery, Department of Surgery, University of Kansas Cancer Center, Kansas City, KS, USA. JWagner@kumc.edu.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2018 Oct; Vol. 25 (10), pp. 2948-2952. Date of Electronic Publication: 2018 Jul 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Dielectric Spectroscopy* , Self Care*, Breast Neoplasms/*therapy , Lymphedema/*diagnosis , Lymphedema/*prevention & control, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Axilla ; Breast Neoplasms/complications ; Breast Neoplasms/surgery ; Compression Bandages ; Female ; Humans ; Lymph Node Excision/adverse effects ; Lymphedema/etiology ; Lymphedema/therapy ; Mastectomy/adverse effects ; Middle Aged ; Population Surveillance ; Postoperative Period ; Prospective Studies ; Radiotherapy/adverse effects ; Taxoids/adverse effects

المؤلفون: Bhatti S; Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, Anne P. O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, and Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; and David R. Hout, Rob S. Seitz, and Daniel B. Bailey, Insight Genetics, Nashville, TN., Heldstab J; Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, Anne P. O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, and Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; and David R. Hout, Rob S. Seitz, and Daniel B. Bailey, Insight Genetics, Nashville, TN., Lehn C; Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, Anne P. O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, and Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; and David R. Hout, Rob S. Seitz, and Daniel B. Bailey, Insight Genetics, Nashville, TN., Tawfik O; Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, Anne P. O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, and Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; and David R. Hout, Rob S. Seitz, and Daniel B. Bailey, Insight Genetics, Nashville, TN., Ash RM; Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, Anne P. O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, and Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; and David R. Hout, Rob S. Seitz, and Daniel B. Bailey, Insight Genetics, Nashville, TN., Hout DR; Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, Anne P. O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, and Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; and David R. Hout, Rob S. Seitz, and Daniel B. Bailey, Insight Genetics, Nashville, TN., Seitz RS; Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, Anne P. O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, and Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; and David R. Hout, Rob S. Seitz, and Daniel B. Bailey, Insight Genetics, Nashville, TN., Bailey DB; Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, Anne P. O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, and Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; and David R. Hout, Rob S. Seitz, and Daniel B. Bailey, Insight Genetics, Nashville, TN., O'Dea AP; Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, Anne P. O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, and Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; and David R. Hout, Rob S. Seitz, and Daniel B. Bailey, Insight Genetics, Nashville, TN., Jensen RA; Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, Anne P. O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, and Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; and David R. Hout, Rob S. Seitz, and Daniel B. Bailey, Insight Genetics, Nashville, TN., Fan F; Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, Anne P. O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, and Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; and David R. Hout, Rob S. Seitz, and Daniel B. Bailey, Insight Genetics, Nashville, TN., Khan QJ; Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, Anne P. O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, and Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; and David R. Hout, Rob S. Seitz, and Daniel B. Bailey, Insight Genetics, Nashville, TN., Godwin AK; Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, Anne P. O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, and Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; and David R. Hout, Rob S. Seitz, and Daniel B. Bailey, Insight Genetics, Nashville, TN., Sharma P; Sajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan M. Ash, Anne P. O'Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, and Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; and David R. Hout, Rob S. Seitz, and Daniel B. Bailey, Insight Genetics, Nashville, TN.

المصدر: JCO precision oncology [JCO Precis Oncol] 2017 Nov; Vol. 1, pp. 1-6.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Tawfik O; Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, 66160, USA. otawfik@kumc.edu, Davis K, Kimler BF, Davis MK, Hull S, Fan F, Khan QJ, O'Dea AP, Thomas P

المصدر: Annals of clinical and laboratory science [Ann Clin Lab Sci] 2010 Fall; Vol. 40 (4), pp. 315-23.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: Institute for Clinical Science Country of Publication: United States NLM ID: 0410247 Publication Model: Print Cited Medium: Internet ISSN: 1550-8080 (Electronic) Linking ISSN: 00917370 NLM ISO Abbreviation: Ann Clin Lab Sci Subsets: MEDLINE

مواضيع طبية MeSH: Black or African American* , Receptor, ErbB-2*/analysis , Receptors, Estrogen*/analysis , Receptors, Progesterone*/analysis , White People*, Breast Neoplasms/*metabolism , Breast Neoplasms/*pathology, Biomarkers, Tumor/metabolism ; Disease-Free Survival ; Female ; Humans ; Immunohistochemistry ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Proteins/metabolism ; Time Factors

المؤلفون: Khan QJ; The University of Kansas Medical Center, 3901 Rainbow Boulevard., Kansas City, KS 66160, USA., O'Dea AP, Sharma P

المصدر: Journal of oncology [J Oncol] 2010; Vol. 2010. Date of Electronic Publication: 2010 Aug 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Hindawi Publishing Corporation Country of Publication: Egypt NLM ID: 101496537 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1687-8469 (Electronic) Linking ISSN: 16878450 NLM ISO Abbreviation: J Oncol Subsets: PubMed not MEDLINE

المؤلفون: Khan QJ; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA. qkhan@kumc.edu, Reddy PS, Kimler BF, Sharma P, Baxa SE, O'Dea AP, Klemp JR, Fabian CJ

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2010 Jan; Vol. 119 (1), pp. 111-8. Date of Electronic Publication: 2009 Aug 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Dietary Supplements*, Antineoplastic Agents/*therapeutic use , Arthralgia/*therapy , Breast Neoplasms/*drug therapy , Fatigue/*drug therapy , Nitriles/*therapeutic use , Triazoles/*therapeutic use , Vitamin D/*analogs & derivatives , Vitamin D/*therapeutic use, Aged ; Aromatase Inhibitors/therapeutic use ; Arthralgia/drug therapy ; Arthralgia/prevention & control ; Chemotherapy, Adjuvant ; Cohort Studies ; Female ; Humans ; Letrozole ; Middle Aged ; Postmenopause ; Treatment Outcome ; Vitamin D/blood ; Vitamin D Deficiency/drug therapy

المؤلفون: Khan QJ; University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, Kansas 66160, USA. qkhan@kumc.edu., Kimler BF, O'Dea AP, Zalles CM, Sharma P, Fabian CJ

المصدر: Breast cancer research : BCR [Breast Cancer Res] 2007; Vol. 9 (3), pp. R35.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Print Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Breast/*cytology , Breast Neoplasms/*genetics , Ki-67 Antigen/*genetics , Mammography/*methods, Adult ; Biopsy ; Biopsy, Fine-Needle ; Breast/pathology ; Breast Neoplasms/epidemiology ; Breast Neoplasms/pathology ; Cohort Studies ; Estrogen Replacement Therapy ; Female ; Gene Expression Regulation ; Humans ; Hyperplasia ; Middle Aged ; Postmenopause ; Premenopause ; Regression Analysis ; Risk Factors